PTGDS and Alzheimer disease: Thus, chronic PGD2 release as a result on enhanced neuroinflammation linked to AD could on the one hand damage neurons via its DP2 receptor, and on the other hand increase the levels of activated/amoeboid microglia via its DP1 receptor.